Oral mexiletine in high-risk patients after myocardial infarction.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008801:Mexiletine / Q000008:administration & dosage* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality*; D011437:Propylamines / Q000008:administration & dosage*; D011897:Random Allocation; D012306:Risk
D011437:Propylamines; D008801:Mexiletine